Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis
The Journal of Physiology · 2023-07 · 601 (14) · 2801-2826
DOI: 10.1113/jp284289 ↗At a glance
Übersichtsarbeit in The Journal of Physiology, published online on 2023-06-08. Written by Umut Rende and 4 co-authors. Institution: School of Biomedical Engineering, The University of New South Wales, Sydney, NSW, Australia. Major MEDLINE topics: Kidney, Renal Insufficiency, Chronic. Cited 44 times so far (Crossref); 136 references. The full text is freely available (open access, CC BY 4.0). Funded by: NSW Health, NSW Health PhD Partnership Program Scholarship.
Abstract (original language)
Renal fibrosis is the final common pathophysiological pathway in chronic kidney disease (CKD) regardless of the underlying cause of kidney injury. Tubulointerstitial fibrosis (TIF) is considered to be the key pathological predictor of CKD progression. Currently, the gold‐standard tool to identify TIF is kidney biopsy, an invasive method that carries risks. Non‐invasive diagnostics rely on an estimation of glomerular filtration rate and albuminuria to assess kidney function, but these fail to diagnose early CKD accurately or to predict progressive decline in kidney function. In this review, we summarize the current and emerging molecular biomarkers that have been studied in various clinical settings and in animal models of kidney disease and that are correlated with the degree of TIF. We examine the potential of these biomarkers to diagnose TIF non‐invasively and to predict disease progression. We also examine the potential of new technologies and non‐invasive diagnostic approaches in assessing TIF. Limitations of current and potential biomarkers are discussed and knowledge gaps identified. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Biomedical Engineering, The University of New South Wales, Sydney, NSW, Australia.
- Macquarie Medical School, Faculty of Medicine, Health & Human Sciences, Macquarie University, NSW, Australia.
- Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia.
ORCID profiles: Umut Rende, Sonia Saad
Funding
- NSW Health
- NSW Health PhD Partnership Program Scholarship
Cite
APA
Rende, U., Guller, A., Goldys, E. M., Pollock, C., & Saad, S. (2023). Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis. The Journal of Physiology, 601(14), 2801-2826. https://doi.org/10.1113/jp284289
Vancouver
Rende U, Guller A, Goldys EM, Pollock C, Saad S. Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis. The Journal of Physiology. 2023;601(14):2801-2826. doi:10.1113/jp284289
BibTeX
@article{Rende2023,
author = {Rende, Umut and Guller, Anna and Goldys, Ewa M and Pollock, Carol and Saad, Sonia},
title = {Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis},
journal = {The Journal of Physiology},
year = {2023},
volume = {601},
number = {14},
pages = {2801--2826},
doi = {10.1113/jp284289}
}
EUVIMED